Скачать или смотреть What Today’s Engagement Trends Signal for the Future of Clinical Trials - Voices of SCOPE

Today I chatted with Sam Rogers, Director of Patient Engagement and Patient-Centered Innovation at Raven RA Ventures, to unpack what she’s seeing across dozens of active trials as a judge for SCOPE’s Participant Engagement Award. Sam talks about the rapid rise of AI in patient engagement, what’s genuinely helpful vs. hype, and why this year’s submissions show a major shift in how the industry views patient experience.

She also highlights the growing influence of direct-to-consumer models, new levels of transparency, and how commercial trends are beginning to reshape expectations in R&D. The theme running through it all: patients are finally being treated like the end users they’ve always been.

Key Takeaways
• AI is showing up everywhere in engagement, with quality improving fast
• Patients are increasingly viewed as true consumers with expectations to match
• Direct-to-consumer models may signal what’s coming for R&D
• Stronger links between commercial and clinical could unlock more meaningful relationships with patients

#VoicesOfSCOPE #SCOPEsummit #ClinicalTrials #PatientEngagement #ParticipantExperience #ClinicalResearch #Pharma #LifeSciences #ClinicalOperations #PatientCentricity #Innovation
__________________________________________________________________________

Join the SCOPE 365 Community & Stay Informed about the Entire Clinical Trials Industry!
📰 Clinical Research News Online: https://bit.ly/4ndSLTa
🎟️ SCOPE Summit: https://bit.ly/3JJtJNf
🎫 SCOPE Summit Europe: https://bit.ly/45OHhjh
🤝 ClinEco - Clinical Trials Ecosystem & Marketplace: https://bit.ly/47KxsnR
🔗 SCOPE 365 LinkedIn Community: https://bit.ly/3VyhoOw